YWC: Young Women's CoOp Study

Sponsor
RTI International (Other)
Overall Status
Completed
CT.gov ID
NCT01224184
Collaborator
Centers for Disease Control and Prevention (U.S. Fed)
237
2
2
40
118.5
3

Study Details

Study Description

Brief Summary

The purpose of this study is to test the efficacy of a cultural-, age- and gender-focused Human Immunodeficiency Virus (HIV) prevention intervention in reducing risk behaviors among African-American young women relative to general health intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Young Women's CoOp
  • Behavioral: Staying Healthy and Eating Well
N/A

Detailed Description

This study completed an extensive formative phase to adapt the Women's CoOp intervention to specifically address the needs of young out-of-school adolescent African-American females with regard to knowledge about sexually transmitted infections (STIs), HIV and sexuality, health consequences of substance abuse, relationships with males, condom communication and social support, and HIV risk-reduction and violence prevention methods. During this phase, in-depth interviews, focus groups, pretesting and pilot testing were conducted to adapt and refine the intervention for the clinical trial.

The aim of this trial is to:

• Evaluate the efficacy of the cultural-, age-, and gender-focused intervention (Young Women's CoOp) relative to an equal attention control nutrition intervention in terms of changes in behaviors (e.g., condom use, substance use, violence prevention).

At study enrollment/baseline, participants completed a questionnaire and baseline drug and pregnancy testing, and were randomized into one of two programs: Young Women's CoOp or Staying Healthy and Eating Well (Nutrition)-both which included 3 individual intervention sessions and 1 group activity. Follow-ups were conducted 3-months post-intervention and 6-months post-intervention and included a questionnaire and drug testing.

The study has since been completed and analysis and manuscript preparation is underway. Two abstracts have been accepted to American Public Health Association conferences in 2012 and 2013. The five papers in progress or published include:

  1. Efficacy of the Young Women's Coop - analysis complete, manuscript being drafted

  2. Summary of qualitative findings from interviews and focus groups - published September 2013

  3. Homelessness and abuse- in final preparation

  4. Correlates of gang affiliation - manuscript complete, CDC clearance obtained, under review.

  5. Post intervention social determinants - re-analyses and re-write

Study Design

Study Type:
Interventional
Actual Enrollment :
237 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Adapting the Women's CoOp for At-Risk Teens
Study Start Date :
May 1, 2010
Actual Primary Completion Date :
Sep 1, 2013
Actual Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Nutrition

Participants in this group will participate in three individual sessions and one group session of the nutrition intervention about healthy eating, physical activity and general wellness.

Behavioral: Staying Healthy and Eating Well
Participants in this group will participate in three individual sessions and one group session of the nutrition intervention about healthy eating, physical activity and general wellness.

Experimental: Young Women's

Participants in this group will participate in three individual sessions and one group session of the young woman-focused intervention about HIV/STIs, pregnancy, alcohol and other drug use, violence, gangs and other issues. This intervention is an adaptation of the evidence-based Women's CoOp (Principal Investigator (PI): Dr. Wendee M. Wechsberg).

Behavioral: Young Women's CoOp
Participants in this group will participate in three individual sessions and one group session of the young woman-focused intervention about HIV/STIs, pregnancy, alcohol and other drug use, violence, gangs and other issues. This intervention is an adaptation of the evidence-based Women's CoOp (PI: Dr. Wendee M. Wechsberg).

Outcome Measures

Primary Outcome Measures

  1. Changes in behaviors, including condom use, substance use and violence prevention [3, and 6- months post-intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 19 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female

  • Black/African-American

  • 16-19 years of age

  • Have dropped out of school at least once or are having problems that they have considered dropping out of school, and have not yet completed high school or GED program

  • Have not graduated from a high school or alternative school, or completed a General Education Development (GED) program

  • Have had vaginal sex at least once in the past 90 days with a male partner

  • Have used one of the following at least once in the past 90 days--alcohol, marijuana, cocaine/crack, heroin, ecstasy, methamphetamine, any prescription drugs not prescribed to them, or any other illicit substance.

  • Will be in the area for the next 8 months

  • Has not participated in previous formative activities of the study (e.g., interviews, focus groups, pretesting and pilot testing),

Exclusion Criteria:
  • Not interested in coming to a health behavior study

  • Not able to attend 4 sessions and 2 follow ups

Contacts and Locations

Locations

Site City State Country Postal Code
1 RTI International; Substance Abuse Treatment Evaluations and Interventions (SATEI) Community-Based Field Site - Durham Durham North Carolina United States 27703
2 RTI International - Headquarters Research Triangle Park North Carolina United States 27709

Sponsors and Collaborators

  • RTI International
  • Centers for Disease Control and Prevention

Investigators

  • Principal Investigator: Wendee M Wechsberg, PhD, RTI International

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
RTI International
ClinicalTrials.gov Identifier:
NCT01224184
Other Study ID Numbers:
  • 5UR6PS000665-04
First Posted:
Oct 19, 2010
Last Update Posted:
Oct 17, 2013
Last Verified:
Oct 1, 2013

Study Results

No Results Posted as of Oct 17, 2013